CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


13-January-2015
Antiretroviral Certified Spiking Solutions® now available from Cerilliant - Nevirapine & Efavirenz.

Efavirenz, 1.0 mg/mL, 1 mL E-109
1.0 mg/mL in Acetonitrile

Known by trade names such as Sustiva®, Stocrin®, and Efavir®, efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used primarily to treat HIV infection or AIDS. This Certified Spiking Solution® is suitable for use as starting materials in the preparation of calibrators, controls, or linearity standards for a variety of LC-MS/MS or GC/MS testing applications including therapeutic drug monitoring (TDM) and clinical and diagnostic testing. Efavirenz has been shown to lower the effectiveness of co-administered drugs such as protease inhibitors, immunosuppressants, and azole antifungals. 
 

Nevirapine, 1.0 mg/mL, 1 mL N-098
1.0 mg/mL in Methanol

A non-nucleoside reverse transcriptase inhibitor (NNRTI) antiretroviral, nevirapine is prescribed to treat human immunodeficiency virus (HIV) infection. Nevirapine exhibits drug-drug interactions with antifungals, forms of hormonal contraception, and other antiretrovirals. This Certified Spiking Solution® is suitable for clinical and diagnostic testing or therapeutic drug monitoring of nevirapine in patient blood, serum, or plasma samples by LC-MS/MS or GC/MS.

Coming soon from Cerilliant - Certified Spiking Solutions® of the antiretrovirals - Zidovudine (Z-011), Ritonavir (R-022), & Levofloxacin (L-038).


Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn